» Articles » PMID: 1718239

Galanin Immunoreactivity in Neuroendocrine Tumors

Overview
Specialty Pathology
Date 1991 Sep 1
PMID 1718239
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

We investigated immunoreactivity for galanin, a 29-amino acid peptide, in formalin-fixed, paraffin-embedded sections of 123 neuroendocrine tumors. Galanin-immunoreactive cells were found in one of 12 hypothalamic gangliocytomas, nine of 18 adrenal pheochromocytomas, nine of 14 pituitary corticotroph adenomas, and one of two thymic endocrine tumors. In pheochromocytomas, galanin-immunoreactive cells were seen either singly or in clusters. In corticotroph adenomas, many tumor cells were positive for galanin, indicating colocalization of corticotropin and galanin in the same tumor cells. No galanin-immunoreactive cells were noted in four extra-adrenal paragangliomas; 10 medullary carcinomas of the thyroid; 35 endocrine tumors arising in the lung, pancreas, and gastrointestinal tract; and 28 pituitary adenomas composed of cells other than corticotrophs. In nontumorous counterparts of these neuroendocrine tumors, galanin immunoreactivity was observed in nerve cells of the hypothalamus, nerve fibers of the duodenum, and adenohypophyseal cells corresponding to corticotrophs. These findings indicate that galanin expression in neuroendocrine tumors is uncommon and restricted to some tumor types.

Citing Articles

The Galaninergic System: A Target for Cancer Treatment.

Sanchez M, Covenas R Cancers (Basel). 2022; 14(15).

PMID: 35954419 PMC: 9367524. DOI: 10.3390/cancers14153755.


Galanin System in Human Glioma and Pituitary Adenoma.

Falkenstetter S, Leitner J, Brunner S, Rieder T, Kofler B, Weis S Front Endocrinol (Lausanne). 2020; 11:155.

PMID: 32265844 PMC: 7105811. DOI: 10.3389/fendo.2020.00155.


Corticotroph (Basophil) invasion of the pars nervosa in the human pituitary: Localization of proopiomelanocortin peptides, galanin and peptidylglycine α-amidating monooxygenase-like immunoreactivities.

Lloyd R, DAmato C, Thiny M, Jin L, Hicks S, Chandler W Endocr Pathol. 2020; 4(2):86-94.

PMID: 32138413 DOI: 10.1007/BF02914457.


Galanin and its receptors in neurological disorders.

Lundstrom L, Elmquist A, Bartfai T, Langel U Neuromolecular Med. 2005; 7(1-2):157-80.

PMID: 16052044 DOI: 10.1385/NMM:7:1-2:157.


Galanin and galanin receptor expression in neuroblastic tumours: correlation with their differentiation status.

Perel Y, Amrein L, Dobremez E, Rivel J, Daniel J, Landry M Br J Cancer. 2002; 86(1):117-22.

PMID: 11857022 PMC: 2746536. DOI: 10.1038/sj.bjc.6600019.